02/19/2025 03:57
Celltrion Expands Biosimilar Portfolio in the European Union Following European Commission Approval of Two Biosimilars

Celltrion today announced that the European Commission (EC) has granted marketing authorization for three products across two biosimilars: Eydenzelt® (CT-P42, aflibercept), a biosimilar to Eylea® to treat multiple retinal disorders, including neovascular (wet) age-related macular degeneration (AMD), macular edema following retinal vein occlusion (RVO, branch RVO or central RVO), diabetic macular edema (DME) and myopic choroidal neovascularisation (myopic CNV); and Stoboclo® and Osenvelt® (CT-P4...

Topshots of the Week (17-23 August, 2024)

A selection of some of the most striking photographs taken by AFP photojournalists from August 17th to August 23th, 2024.


Women wearing traditional clothes

Women wearing traditional hanbok dresses visit the Gyeongbokgung Palace in Seoul on August 19, 2024.
© Anthony WALLACE / AFP